The COVID-19 pandemic's early death toll was much higher than the official U.S. count, according to a new study that ...

BOSTON, MA / ACCESS Newswire / March 2, 2026 / Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company developing carbohydrate-based therapeutics, today announced results from a ...

The 2024-2025 mRNA COVID-19 vaccine provided moderate protection against severe outcomes, including hospitalizations and ED visits.

When that person coughs, sneezes, kisses, or shares saliva and throat secretions, tiny droplets containing the bacteria leave ...

A fourth dose of bivalent or monovalent BA.1-adapted BNT162b2 vaccines was safe and elicited robust neutralizing responses in adults aged 18 to 55 years.

High-dose Vitamin D doesn't reduce acute COVID severity but shows a promising signal for reducing Long COVID and brain fog.

The 2025 Interdisciplinary Research Grant (IRG) for Convergent Innovation is designed to contribute to CUNY’s goal of amplifying the quantity and quality of engaged public impact research and ...

Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

Moderna’s Omicron-adapted COVID-19 vaccines appear to reduce the risk of hospitalization and death in adults who are not ...

In this letter, I’m going to offer a possible way of thinking about long COVID symptoms and how to treat them.

A randomized clinical trial found that metformin and ursodeoxycholic acid (UDCA) did not improve recovery rates in people with long COVID compared with placebo. The findings highlight the need for ...

Although a number of studies have found that a diabetes drug called metformin reduces the risk of long COVID, new research finds that it does not reduce symptoms of the condition.